Every day, the United States is recording thousands of new coronavirus cases, a worrying trend that has caused panic. As a result, the government is considering to carry out “Pool Testing.” The White House Coronavirus Task Force says that it will be engaging PharmaCyte Biotech Inc (OTCMKTS:PMCB) for sample pooling.
Speaking in an interview with CNBC, the director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, emphasized the need to rethink idea of safeguarding the population and the economy. This, he said, would be accomplished through carrying out more tests.
Pharmacyte’s COVID-19 Testing Kits Have the Precise Capability
The California-based biotechnology company has its COVID-19 testing kits licensed from Hai Kang Life Corporation in Hong Kong. According to Dr. Fauci, the kits are ideally suited for mass testing; thus, they are likely to make a significant difference. They are also reportedly ten times more sensitive than the ordinary tests and can detect the virus below the threshold.
Professor Albert Cheung-Hoi Yu, the developer of the test kits, says that with the looming speculation of a second wave of the SARS-CoV-2 (COVID-19), random screening is imperative in a bid to counter its re-emergence.
How is the sample pooling accomplished?
The ability to test hundreds of people at once will quicken the creation of a safer environment for communities, organizations, schools, companies, and government agencies. It would also expedite the screening process and accuracy.
The task involves swabbing a large group, and each sample is pooled into 1 “test reaction.” Negative results indicate that everyone in that group is safe. However, positive results would lead to individual testing of everyone in that pool to determine who among them is infected.
“Pooling would give us the capacity to go from half a million tests a day to potentially 5 million individuals tested per day,” Dr. Fauci and Dr. Deborah Birx explained. The two are playing leading roles on the White House Coronavirus Task Force.
Meanwhile, the general feeling is that even with the massive testing, the disease is likely to become seasonal in the United States and may go beyond 2020 and potentially forever.